Status:

UNKNOWN

MyPal ePRO-based Early Palliative Care System in Adult Patients With Hematologic Malignancies

Lead Sponsor:

Centre for Research and Technology Hellas

Conditions:

Chronic Lymphocytic Leukemia

Myelodysplastic Syndromes

Eligibility:

All Genders

Phase:

NA

Brief Summary

Randomized unblinded interventional clinical trial: Arm Intervention Experimental arm (n=150): Intervention group Administration of the MyPal ePRO system the intervention group will use the ePRO tool...

Detailed Description

The MyPal eHealth system coincides with the MyPal intervention. The system will be used primarily by the patients that participate in the intervention arm of the trial and secondarily by the participa...

Eligibility Criteria

Inclusion

  • Adults (≥18 years)
  • Diagnosed with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) or myelodysplastic syndrome (MDS)
  • Scheduled to receive any line of treatment for CLL/SLL or MDS or who have been previously exposed to any treatment for CLL or MDS
  • Able to understand and communicate in the respective language
  • Users of an Internet connected device (smart phone/tablet)

Exclusion

  • Patients who are already participating in another experimental study
  • Patients needing immediate referral for specialized palliative care
  • Any life-threatening illness, medical condition, or organ system dysfunction that, in the investigator's opinion, could compromise the subject's safety or put the study outcomes at undue risk
  • Patients unable to provide written informed consent
  • Life expectancy \<3 months
  • For CLL cohort: patients who have experienced Richter transformation

Key Trial Info

Start Date :

January 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2022

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT04370457

Start Date

January 1 2021

End Date

September 30 2022

Last Update

August 4 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

IRCCS Ospedale San Raffaele

Milan, Italy, 20132